Skip to search.
 FTSE 100 Up 1.16%

Kite Pharma, Inc. (KITE)

-NasdaqGS
71.11 Down 0.80(1.11%) 29 Jul 21:00
|After Hours: : 70.90 Down 0.21 (0.29%) 21:15
Add to Portfolio
Prev Close:71.91
Open:71.79
Bid:71.25 x 200
Ask:72.99 x 100
1y Target Est:84.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:69.53 - 72.74
52wk Range:21.01 - 89.21
Volume:481,784
Avg Vol (3m):1,176,030
Market Cap:3.06b
P/E (ttm):N/A
EPS (ttm):-1.72
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEDown 1.11%3.06b
CELGDown 2.42%104.81b
NVSUp 0.88%250.43b
PFEUp 1.16%220.20b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,074.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.69
Quarterly EPS Est (Jun-15) :-0.40
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback